Acute binge pattern cocaine administration induces region-specific effects in D1-r- and D2-r-expressing cells in eGFP transgenic mice

Neuroscience

Volumn 253, Issue , 2013, Pages 123-131

  Lawhorn, C ^a   Edusei, E ^a,b   Zhou, Y ^a   Ho, A ^a   Kreek, M J ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Addiction; Cocaine; Dopamine; EGFP; Stereology; Striatum

Indexed keywords

COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; ENHANCED GREEN FLUORESCENT PROTEIN; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL COUNT; COCAINE DEPENDENCE; COMPUTER PROGRAM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORPUS STRIATUM; DORSOLATERAL STRIATUM; DRD1 GENE; DRD2 GENE; GENE; GENE EXPRESSION; MOUSE; MULTIPHOTON MICROSCOPY; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSGENIC MOUSE;

ADDICTION; ANALYSIS OF VARIANCE; ANOVA; BAC; BACTERIAL ARTIFICIAL CHROMOSOME; COCAINE; D1-R; D1-RECEPTOR; D2-R; D2-RECEPTOR; DL; DOPAMINE; DORSOLATERAL; EGFP; ENHANCED GREEN FLUORESCENT PROTEIN; MEDIUM SPINY NEURON; MSN; NAC; NUCLEUS ACCUMBENS; PARAFORMALDEHYDE; PFA; SN; STEREOLOGY; STRIATUM; SUBSTANTIA NIGRA;

ANALYSIS OF VARIANCE; ANIMALS; CELL COUNT; COCAINE; COCAINE-RELATED DISORDERS; CORPUS STRIATUM; DOPAMINE UPTAKE INHIBITORS; GREEN FLUORESCENT PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; NUCLEUS ACCUMBENS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; TIME FACTORS;

EID: 84884543187     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.08.032     Document Type: Article

References (42)

1. Berendse H.W., Groenewegen H.J., Lohman A.H. Compartmental distribution of ventral striatal neurons projecting to the mesencephalon in the rat. J Neurosci 1992, 12(6):2079-2103.
2. Bertran-Gonzalez J., Bosch C., Maroteaux M., Matamales M., Hervé D., Valjent E., Girault J.A. Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 2008, 28(22):5671-5685.
3. Brown C.A., Campbell M.C., Karimi M., Tabbal S.D., Loftin S.K., Tian L.L., Moerlein S.M., Perlmutter J.S. Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys. Exp Neurol 2012, 236(1):190-197.
4. Canales J.J., Capper-Loup C., Hu D., Choe E.S., Upadhyay U., Graybiel A.M. Shifts in striatal responsivity evoked by chronic stimulation of dopamine and glutamate systems. Brain 2002, 125:2353-2363.
5. Corish P., Tyler-Smith C. Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng 1999, 12(12):1035-1040.
6. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. J Neural Transm Suppl 1992, 36:43-59.
7. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990, 250(4986):1429-1432.
8. Gong S., Kus L., Heintz N. Rapid bacterial artificial chromosome modification for large-scale mouse transgenesis. Nat Protoc 2010, 5(10):1678-1696.
9. Grillner S., Hellgren J., Ménard A., Saitoh K., Wikström M.A. Mechanisms for selection of basic motor programs-roles for the striatum and pallidum. Trends Neurosci 2005, 28(7):364-370.
10. Gundersen H.J., Jensen E.B. The efficiency of systematic sampling in stereology and its prediction. J Microsc 1987, 147:229-263.
11. Heintz N. BAC to the future: the use of bac transgenic mice for neuroscience research. Nat Rev Neurosci 2001, 2(12):861-870.
12. Hikida T., Kimura K., Wada N., Funabiki K., Nakanishi S. Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior. Neuron 2010, 66(6):896-907.
13. Humphries M.D., Prescott T.J. The ventral basal ganglia, a selection mechanism at the crossroads of space, strategy, and reward. Prog Neurobiol 2010, 90(4):385-417.
14. Ito R., Robbins T.W., Everitt B.J. Differential control over cocaine-seeking behavior by nucleus accumbens core and shell. Nat Neurosci 2004, 7(4):389-397.
15. Kramer P.F., Christensen C.H., Hazelwood L.A., Dobi A., Bock R., Sibley D.R., Mateo Y., Alvarez V.A. Dopamine D2 receptor overexpression alters behavior and physiology in Drd2-EGFP mice. J Neurosci 2011, 31(1):126-132.
16. Kreek M.J., Schlussman S.D., Reed B., Zhang Y., Nielsen D.A., Levran O., Zhou Y., Butelman E.R. Bidirectional translational research: progress in understanding addictive diseases. Neuropharmacology 2009, 56(Suppl. 1):32-43.
17. Lawhorn C., Smith D.M., Brown L.L. Striosome-matrix pathology and motor deficits in the YAC128 mouse model of Huntington's disease. Neurobiol Dis 2008, 32(3):471-478.
18. Lawhorn C., Smith D.M., Brown L.L. Partial ablation of mu-opioid receptor rich striosomes produces deficits on a motor-skill learning task. Neuroscience 2009, 163(1):109-119.
19. Luo Z., Volkow N.D., Heintz N., Pan Y., Du C. Acute cocaine induces fast activation of D1 receptor and progressive deactivation of D2 receptor striatal neurons: in vivo optical microprobe [Ca2+]i imaging. J Neurosci 2011, 31(37):13180-13190.
20. Maggos C.E., Tsukada H., Kakiuchi T., Nishiyama S., Myers J.E., Kreuter J., Schlussman S.D., Unterwald E.M., Ho A., Kreek M.J. Sustained withdrawal allows normalization of in vivo [11C]N-methylspiperone dopamine D2 receptor binding after chronic binge cocaine: a positron emission tomography study in rats. Neuropsychopharmacology 1998, 19(2):146-153.
21. Mantsch J.R., Ho A., Schlussman S.D., Kreek M.J. Predictable individual differences in the initiation of cocaine self-administration by rats under extended-access conditions are dose-dependent. Psychopharmacology (Berl) 2001, 157(1):31-39.
22. Matamales M., Bertran-Gonzalez J., Salomon L., Degos B., Deniau J.M., Valjent E., Hervé D., Girault J.A. Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice. PLoS One 2009, 4(3):e4770.
23. Palacios J.M., Camps M., Cortés R., Probst A. Mapping dopamine receptors in the human brain. J Neural Transm Suppl 1988, 27:227-235.
24. Picetti R., Ho A., Butelman E.R., Kreek M.J. Dose preference and dose escalation in extended-access cocaine self-administration in Fischer and Lewis rats. Psychopharmacology (Berl) 2010, 211(3):313-323.
25. Puig S., Noble F., Benturquia N. Short- and long-lasting behavioral and neurochemical adaptations: relationship with patterns of cocaine administration and expectation of drug effects in rats. Transl Psychiatry 2012, 23:2.
26. Robertson G.S., Vincent S.R., Fibiger H.C. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience 1992, 49(2):285-296.
27. Schmitz C., Hof P.R. Design-based stereology in neuroscience. Neuroscience 2005, 130(4):813-831.
28. Seeman P., Niznik H.B. Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB J 1990, 4(10):2737-2744.
29. Seeman P., Bzowej N.H., Guan H.C., Bergeron C., Reynolds G.P., Bird E.D., Riederer P., Jellinger K., Tourtellotte W.W. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. Neuropsychopharmacology 1987, 1(1):5-15.
30. Suto N., Wise R.A. Satiating effects of cocaine are controlled by dopamine actions in the nucleus accumbens core. J Neurosci 2011, 31(49):17917-17922.
31. Tsukada H., Kreuter J., Maggos C.E., Unterwald E.M., Kakiuchi T., Nishiyama S., Futatsubashi M., Kreek M.J. Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain: an in vivo study using positron emission tomography. J Neurosci 1996, 16(23):7670-7677.
32. Unterwald E.M., Ho A., Rubenfeld J.M., Kreek M.J. Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration. J Pharmacol Exp Ther 1994, 270(3):1387-1396.
33. Volkow N.D., Fowler J.S., Wang G.J., Baler R., Telang F., Voorn P., Gerfen C.R. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 2009, 56(Suppl. 1):3-8.
34. Voorn P., Gerfen C.R., Groenewegen H.J. Compartmental organization of the ventral striatum of the rat: immunohistochemical distribution of enkephalin, substance P, dopamine, and calcium-binding protein. J Comp Neurol 1989, 289(2):189-201.
35. Wilson C.J., Groves P.M. Fine structure and synaptic connections of the common spiny neuron of the rat neostriatum: a study employing intracellular inject of horseradish peroxidase. J Comp Neurol 1980, 194(3):599-615.
36. Zhang R., Oorschot D.E. Total number of neurons in the habenular nuclei of the rat epithalamus: a stereological study. J Anat 2006, 208(5):577-585.
37. Zhang Y., Schlussman S.D., Ho A., Kreek M.J. Effect of chronic "binge cocaine" on basal levels and cocaine-induced increases of dopamine in the caudate putamen and nucleus accumbens of C57BL/6J and 129/J mice. Synapse 2003, 50(3):191-199.
38. Zhang Y., Svenningsson P., Picetti R., Schlussman S.D., Nairn A.C., Ho A., Greengard P., Kreek M.J. Cocaine self-administration in mice is inversely related to phosphorylation at Thr34 (protein kinase A site) and Ser130 (kinase CK1 site) of DARPP-32. J Neurosci 2006, 26(10):2645-2651.
39. Zhang Y., Schlussman S.D., Butelman E.R., Ho A., Kreek M.J. Effects of withdrawal from chronic escalating-dose binge cocaine on conditioned place preference to cocaine and striatal preproenkephalin mRNA in C57BL/6J mice. Neuropharmacology 2012, 63(2):322-329.
40. Zhou Y., Spangler R., Schlussman S.D., Yuferov V.P., Sora I., Ho A., Uhl G.R., Kreek M.J. Effects of acute "binge" cocaine on preprodynorphin, preproenkephalin, proopiomelanocortin, and corticotropin-releasing hormone receptor mRNA levels in the striatum and hypothalamic-pituitary-adrenal axis of mu-opioid receptor knockout mice. Synapse 2002, 45(4):220-229.
41. Zhou Y., Spangler R., Yuferov V.P., Schlussmann S.D., Ho A., Kreek M.J. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus. Brain Res Mol Brain Res 2004, 130(1-2):61-67.
42. Zhou Y., Litvin Y., Piras A.P., Pfaff D.W., Kreek M.J. Persistent increase in hypothalamic arginine vasopressin gene expression during protracted withdrawal from chronic escalating-dose cocaine in rodents. Neuropsychopharmacology 2011, 36(10):2062-2075.